Hospital
Metro Knoxville Hma LLC
Metro Knoxville Hma LLC was paid $28.70M by Medicaid between Jan 2018 and Dec 2024, across 138 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.
33Billing provider infoMETRO KNOXVILLE HMA LLC
POWELL, TN 37849
POWELL, TN 37849
33aNPI1043292899assigned 11/17/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$28.70M
24GClaims526,481
24DCodes billed138
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#6 of 71
Median peer was paid$6.96M
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 128,295 | $6.92M | |
| 2019 | 88,142 | $4.28M | |
| 2020 | 75,131 | $3.33M | |
| 2021 | 72,540 | $4.33M | |
| 2022 | 57,370 | $3.74M | |
| 2023 | 60,476 | $3.49M | |
| 2024incomplete | 44,527 | $2.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 43,654 | 37,066 | $11.01M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 48,524 | 42,722 | $9.55M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 7.6% | 7,363 | 5,617 | $2.19M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.1% | 6,275 | 5,068 | $1.75M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2.2% | 1,845 | 1,410 | $628K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 4,502 | 4,114 | $557K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.3% | 4,700 | 1,581 | $382K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 21,052 | 17,898 | $283K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 57,840 | 47,481 | $165K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 437 | 370 | $160K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,094 | 8,450 | $154K |
| 87428 | <1% | 3,232 | 2,856 | $131K |
126 more codes
| 80053 | Comprehensive metabolic panel | <1% | 52,250 | $126K |
| 93458 | <1% | 284 | $117K | |
| 95811 | <1% | 779 | $114K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 349 | $102K |
| 62323 | <1% | 603 | $99K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,901 | $94K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 548 | $94K |
| G0378 | Hospital observation service, per hour | <1% | 875 | $91K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 6,085 | $79K |
| 84484 | <1% | 10,862 | $71K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 58,192 | $51K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 8,382 | $49K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,961 | $47K |
| 59025 | Fetal non-stress test | <1% | 965 | $46K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 435 | $40K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 13,195 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,336 | $35K |
| 71045 | Radiologic examination, chest; single view | <1% | 12,803 | $31K |
| 43248 | <1% | 99 | $28K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 565 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,462 | $27K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,933 | $27K |
| 83690 | <1% | 9,424 | $27K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,128 | $25K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 585 | $21K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,437 | $21K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 846 | $19K |
| 81025 | <1% | 10,096 | $19K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 631 | $17K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 684 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,437 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,526 | $12K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 353 | $12K |
| 81001 | <1% | 19,108 | $11K | |
| 80061 | Lipid panel | <1% | 3,009 | $10K |
| 87081 | <1% | 2,875 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,801 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,633 | $6K |
| 76770 | <1% | 163 | $5K | |
| 45384 | <1% | 16 | $5K | |
| 74018 | <1% | 358 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 44 | $5K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 319 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,086 | $4K |
| 84702 | <1% | 374 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,679 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 202 | $3K |
| 83735 | <1% | 1,152 | $3K | |
| 0002A | <1% | 97 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,906 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 183 | $2K |
| 64493 | <1% | 15 | $2K | |
| 85610 | <1% | 1,732 | $2K | |
| 74178 | <1% | 17 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 24 | $1K |
| 85730 | <1% | 873 | $1K | |
| 95806 | <1% | 14 | $1K | |
| 0001A | <1% | 38 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 512 | $952.40 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 65 | $868.82 |
| 83970 | <1% | 32 | $788.03 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 25 | $600.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,833 | $568.41 |
| 81003 | <1% | 1,374 | $525.45 | |
| 83880 | <1% | 131 | $417.32 | |
| 85027 | <1% | 756 | $399.30 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,107 | $377.77 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 26 | $364.56 |
| 83605 | <1% | 93 | $358.70 | |
| 82657 | <1% | 698 | $314.88 | |
| 11045 | <1% | 25 | $307.53 | |
| 82248 | <1% | 369 | $292.42 | |
| 82550 | <1% | 143 | $277.76 | |
| 82077 | <1% | 58 | $272.95 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,034 | $231.55 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 5,702 | $199.64 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 149 | $194.60 |
| 84460 | <1% | 265 | $161.28 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 215 | $153.06 |
| 84144 | <1% | 17 | $151.96 | |
| 84450 | <1% | 173 | $135.36 | |
| 94760 | <1% | 252 | $134.54 | |
| 82728 | <1% | 29 | $118.72 | |
| 82962 | <1% | 3,082 | $107.59 | |
| 83516 | <1% | 48 | $106.93 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $103.68 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 277 | $97.62 |
| 84100 | <1% | 104 | $96.12 | |
| 88342 | <1% | 1,958 | $90.40 | |
| J2704 | Injection, propofol, 10 mg | <1% | 14,127 | $80.49 |
| 83540 | <1% | 41 | $77.44 | |
| 83550 | <1% | 29 | $76.32 | |
| 86140 | <1% | 47 | $75.58 | |
| 87070 | <1% | 232 | $75.00 | |
| 96376 | <1% | 53 | $71.22 | |
| 86850 | <1% | 13 | $70.37 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 468 | $64.20 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,160 | $61.59 |
| 81000 | <1% | 28 | $53.35 | |
| 84481 | <1% | 14 | $46.15 | |
| 80305 | <1% | 16 | $40.41 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 78 | $39.73 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 1,040 | $32.63 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 24 | $29.84 |
| 82043 | <1% | 40 | $25.20 | |
| 84439 | <1% | 14 | $24.55 | |
| 82570 | <1% | 21 | $16.92 | |
| 80076 | <1% | 14 | $4.45 | |
| 91300 | <1% | 95 | $0.06 | |
| C1769 | Guide wire | 0% | 398 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 260 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 86 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 113 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 47 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 34 | $0.00 |
| 80320 | 0% | 14 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 669 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 2,659 | $0.00 |
| 99152 | 0% | 562 | $0.00 | |
| 88313 | 0% | 107 | $0.00 | |
| 87329 | 0% | 24 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 49 | $0.00 |
| 87324 | 0% | 24 | $0.00 | |
| 87328 | 0% | 24 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 22 | $0.00 |
| 83630 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.